|
1
|
Grange C, Collino F, Tapparo M and Camussi
G: Oncogenic micro-RNAs and renal cell carcinoma. Front Oncol.
4:492014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lopez-Beltran A, Carrasco JC, Cheng L,
Scarpelli M, Kirkali Z and Montironi R: 2009 update on the
classification of renal epithelial tumors in adults. Int J Urol.
16:432–443. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Spronsen DJ, de Weijer KJ, Mulders PF
and De Mulder PH: Novel treatment strategies in clear-cell
metastatic renal cell carcinoma. Anticancer Drugs. 16:709–717.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reeves DJ and Liu CY: Treatment of
metastatic renal cell carcinoma. Cancer Chemother Pharmacol.
64:11–25. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Janzen NK, Kim HL, Figlin RA and
Belldegrun AS: Surveillance after radical or partial nephrectomy
for localized renal cell carcinoma and management of recurrent
disease. Urol Clin North Am. 30:843–852. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shao Y, Zhang SQ, Quan F, Zhang PF and Wu
SL: MicroRNA-145 inhibits the proliferation, migration and invasion
of the human TCA8113 oral cancer line. Oncol Lett. 6:1636–1640.
2013.PubMed/NCBI
|
|
8
|
Yang L, Wang YL, Liu S, Zhang PP, Chen Z,
Liu M and Tang H: miR-181b promotes cell proliferation and reduces
apoptosis by repressing the expression of adenylyl cyclase 9 (AC9)
in cervical cancer cells. FEBS Lett. 588:124–130. 2014. View Article : Google Scholar
|
|
9
|
Billeter AT, Barnett RE, Druen D, Polk HC
Jr and van Berkel VH: MicroRNA as a new factor in lung and
esophageal cancer. Semin Thorac Cardiovasc Surg. 24:155–165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eulalio A, Huntzinger E and Izaurralde E:
Getting to the root of miRNA-mediated gene silencing. Cell.
132:9–14. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lytle JR, Yario TA and Steitz JA: Target
mRNAs are repressed as efficiently by microRNA-binding sites in the
5′UTR as in the 3′UTR. Proc Natl Acad Sci USA. 104:9667–9672. 2007.
View Article : Google Scholar
|
|
12
|
Wightman B, Bürglin TR, Gatto J, Arasu P
and Ruvkun G: Negative regulatory sequences in the lin-14
3′-untranslated region are necessary to generate a temporal switch
during Caenorhabditis elegans development. Genes Dev. 5:1813–1824.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lal A, Navarro F, Maher CA, Maliszewski
LE, Yan N, O'Day E, Chowdhury D, Dykxhoorn DM, Tsai P, Hofmann O,
et al: miR-24 Inhibits cell proliferation by targeting E2F2, MYC
and other cell-cycle genes via binding to 'seedless' 3′UTR microRNA
recognition elements. Mol Cell. 35:610–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lerner M, Lundgren J, Akhoondi S, Jahn A,
Ng HF, Akbari Moqadam F, Oude Vrielink JA, Agami R, Den Boer ML,
Grandér D and Sangfelt O: MiRNA-27a controls FBW7/hCDC4-dependent
cyclin E degradation and cell cycle progression. Cell Cycle.
10:2172–2183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ebert PJ, Jiang S, Xie J, Li QJ and Davis
MM: An endogenous positively selecting peptide enhances mature T
cell responses and becomes an autoantigen in the absence of
microRNA miR-181a. Nat Immunol. 10:1162–1169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ventura A, Young AG, Winslow MM, Lintault
L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone
JR, et al: Targeted deletion reveals essential and overlapping
functions of the miR-17 through 92 family of miRNA clusters. Cell.
132:875–886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Curtale G, Citarella F, Carissimi C,
Goldoni M, Carucci N, Fulci V, Franceschini D, Meloni F, Barnaba V
and Macino G: An emerging player in the adaptive immune response:
MicroRNA-146a is a modulator of IL-2 expression and
activation-induced cell death in T lyzmphocytes. Blood.
115:265–273. 2010. View Article : Google Scholar
|
|
19
|
Yu Z, Ni L, Chen D, et al: Identification
of miR-7 as an oncogene in renal cell carcinoma. J Mol Histol.
44:669–677. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng H, Luo J, Hao H, Hu J, Xie SK, Ren D
and Rao B: MicroRNA-100 regulates SW620 colorectal cancer cell
proliferation and invasion by targeting RAP1B. Oncol Rep.
31:2055–2062. 2014.PubMed/NCBI
|
|
21
|
Xie J, Chen M, Zhou J, Mo MS, Zhu LH, Liu
YP, Gui QJ, Zhang L and Li GQ: miR-7 inhibits the invasion and
metastasis of gastric cancer cells by suppressing epidermal growth
factor receptor expression. Oncol Rep. 31:1715–1722.
2014.PubMed/NCBI
|
|
22
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Babashah S and Soleimani M: The oncogenic
and tumour suppressive roles of microRNAs in cancer and apoptosis.
Eur J Cancer. 47:1127–1137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seca H, Almeida GM, Guimarães JE and
Vasconcelos MH: miR signatures and the role of miRs in acute
myeloid leukaemia. Eur J Cancer. 46:1520–1527. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Müller S and Nowak K: Exploring the
miRNA-mRNA regulatory network in clear cell renal cell carcinomas
by next-generation sequencing expression profiles. Biomed Res Int.
2014:9484082014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Osanto S, Qin Y, Buermans HP, Berkers J,
Lerut E, Goeman JJ and van Poppel H: Genome-wide microRNA
expression analysis of clear cell renal cell carcinoma by next
generation deep sequencing. PLoS One. 7:e382982012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou L, Chen J, Li Z, Li X, Hu X, Huang Y,
Zhao X, Liang C, Wang Y, Sun L, et al: Integrated profiling of
microRNAs and mRNAs: MicroRNAs located on Xq27.3 associate with
clear cell renal cell carcinoma. PLoS One. 5:e152242010. View Article : Google Scholar
|
|
30
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
32
|
Su Z, Chen D, Zhang E, et al:
MicroRNA-509-3p inhibits cancer cell proliferation and migration by
targeting the mitogen-activated protein kinase kinase kinase 8
oncogene in renal cell carcinoma. Mol Med Rep. 12:1535–1543.
2015.PubMed/NCBI
|
|
33
|
Patel C, Ahmed A and Ellsworth P: Renal
cell carcinoma: A reappraisal. Urol Nurs. 32:182–190.
2012.PubMed/NCBI
|
|
34
|
Yang SF, Hsu HL, Chao TK, Hsiao CJ, Lin YF
and Cheng CW: Annexin A2 in renal cell carcinoma: Expression,
function and prognostic significance. Urol Oncol. 33:e11–e21. 2015.
View Article : Google Scholar
|
|
35
|
Lang Y, Xu S, Ma J, Wu J, Jin S, Cao S and
Yu Y: MicroRNA-429 induces tumorigenesis of human non-small cell
lung cancer cells and targets multiple tumor suppressor genes.
Biochem Biophys Res Commun. 450:154–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang Y, Dai Y, Yang J, Chen T, Yin Y,
Tang M, Hu C and Zhang L: Microarray analysis of microRNA
expression in renal clear cell carcinoma. Eur J Surg Oncol.
35:1119–1123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Luthra R, Chen H, Roy-Chowdhuri S and
Singh RR: Next-generation sequencing in clinical molecular
diagnostics of cancer: Advantages and challenges. Cancers (Basel).
7. pp. 2023–2036. 2015, View Article : Google Scholar
|
|
38
|
Christensen LL, Tobiasen H, Holm A,
Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH,
Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, et al: MiRNA-362-3p
induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1
and is associated with recurrence of colorectal cancer. Int J
Cancer. 133:67–78. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Van Wynsberghe PM, Chan SP, Slack FJ and
Pasquinelli AE: Analysis of microRNA expression and function.
Methods Cell Biol. 106:219–252. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ishitani T and Ishitani S: Nemo-like
kinase, a multifaceted cell signaling regulator. Cell Signal.
25:190–197. 2013. View Article : Google Scholar
|
|
41
|
Yuzugullu H, Benhaj K, Ozturk N, Senturk
S, Celik E, Toylu A, Tasdemir N, Yilmaz M, Erdal E, Akcali KC, et
al: Canonical wnt signaling is antagonized by noncanonical wnt5a in
hepato-cellular carcinoma cells. Mol Cancer. 8:902009. View Article : Google Scholar
|
|
42
|
Stevens KN, Kelemen LE, Wang X, Fridley
BL, Vierkant RA, Fredericksen Z, Armasu SM, Tsai YY, Berchuck A,
Narod SA, et al: Common variation in nemo-like kinase is associated
with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev.
21:523–528. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yasuda J, Tsuchiya A, Yamada T, Sakamoto
M, Sekiya T and Hirohashi S: Nemo-like kinase induces apoptosis in
DLD-1 human colon cancer cells. Biochem Biophys Res Commun.
308:227–233. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Emami KH, Brown LG, Pitts TE, Sun X,
Vessella RL and Corey E: Nemo-like kinase induces apoptosis and
inhibits androgen receptor signaling in prostate cancer cells.
Prostate. 69:1481–1492. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ,
Xie HJ, Ahn YM, Park WS, Lee JY and Nam SW: Targeted disruption of
Nemo-like kinase inhibits tumor cell growth by simultaneous
suppression of cyclin D1 and CDK2 in human hepatocellular
carcinoma. J Cell Biochem. 110:687–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cui G, Li Z, Shao B, Zhao L, Zhou Y, Lu T,
Wang J, Shi X, Wang J, Zuo G, et al: Clinical and biological
significance of nemo-like kinase expression in glioma. J Clin
Neurosci. 18:271–275. 2011. View Article : Google Scholar
|
